CNBC · TechCrunch
Demis Hassabis’ AI company raises $5 billion, months after he left as Google DeepMind CEO
Tuesday, November 17, 2026
Isomorphic Labs, an AI drug-discovery company spun out of Google's DeepMind in 2021, raised $5 billion in a Series C funding round. The company is developing medicines using AI technology and plans to advance drug candidates into clinical trials. Demis Hassabis, who previously led Google DeepMind as CEO, is associated with Isomorphic Labs.
Reported by 2 outlets:
